Discovery and Pharmacological Evaluation of Growth Hormone Secretagogue Receptor Antagonists-Reference-Cited by-同舟云学术

Discovery and Pharmacological Evaluation of Growth Hormone Secretagogue Receptor Antagonists

Published:2006-06-23 Issue:15 Volume:49 Page:4459-4469
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Xin Zhili¹,Serby Michael D.¹,Zhao Hongyu¹,Kosogof Christi¹,Szczepankiewicz Bruce G.¹,Liu Mei¹,BoLiu, ¹,Hutchins Charles W.¹,Sarris Kathy A.¹,Hoff Ethan D.¹,Falls H. Douglas¹,Lin Chun W.¹,Ogiela Christopher A.¹,Collins Christine A.¹,Brune Michael E.¹,Bush Eugene N.¹,Droz Brian A.¹,Fey Thomas A.¹,Knourek-Segel Victoria E.¹,Shapiro Robin¹,Jacobson Peer B.¹,Beno David W. A.¹,Turner Teresa M.¹,Sham Hing L.¹,Liu Gang¹

Affiliation:

1. Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6098.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm060461g

Reference33 articles.

1. Developments in ghrelin biology and potential clinical relevance

2. Ghrelin is a growth-hormone-releasing acylated peptide from stomach

3. Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors;Biochemical Pharmacology;2022-08

2. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor;Journal of Medicinal Chemistry;2022-02-14

3. Translating biased signaling in the ghrelin receptor system into differential in vivo functions;Proceedings of the National Academy of Sciences;2018-10-09

4. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2018-01-01

5. Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse;PLOS ONE;2017-06-22